CCS
CHE icon

Crosspoint Capital Strategies’s Chemed CHE Stock Holding History

Crosspoint Capital Strategies’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-80
Closed -$10K – 770
2015
Q2 		$10K Buy
+80
New +$9.9K ﹤0.01% 520

Other funds holding CHE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Crosspoint Capital Strategies's CHE Position: Q3 2015 in Review

Crosspoint Capital Strategies sold out of Chemed (CHE) in Q3 2015, closing a stake of 80 shares — an estimated $10K sold.

Crosspoint Capital Strategies first reported a position in CHE in Q2 2015 and held it in 1 quarter. The position peaked at $10K in Q2 2015. 216 funds tracked by Wall St. Rank hold CHE as of Q3 2015.

  • Crosspoint Capital Strategies reported no remaining Chemed position as of Q3 2015 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 80 Chemed shares in Q3 2015, an estimated $10K.
  • Crosspoint Capital Strategies first reported a position in Chemed in Q2 2015 and held it in 1 quarter.
  • Crosspoint Capital Strategies's Chemed position peaked at $10K in Q2 2015.
  • 216 funds tracked by Wall St. Rank held Chemed as of Q3 2015.

Based on Crosspoint Capital Strategies's 13F filing for Q3 2015, filed 25 Nov 2015.